
Glimodom MV 2/0.2 Tablets by Kivonyx Healthcare Pvt. Ltd. contain Glimepiride, Voglibose, and Metformin Hydrochloride (Sustained Release), a prescription combination used for managing Type 2 Diabetes Mellitus in selected adults. Glimepiride stimulates insulin secretion from pancreatic beta cells, while Metformin reduces hepatic glucose production and improves insulin sensitivity. Voglibose delays intestinal carbohydrate digestion, helping control post-meal blood glucose elevations. Glimodom MV 2/0.2 may be prescribed when combination therapy is clinically appropriate and supported by individual blood glucose requirements. Available in blister strip packaging, the medicine should be taken according to a registered medical practitioner's prescription, considering kidney function, hypoglycaemia risk, verified ingredient strengths, dietary habits, and recommended treatment instructions.
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Kivonyx Healthcare Pvt. Ltd. is a leading pharmaceutical company in Ahmedabad, with a primary focus on providing high-quality healthcare products to its clients and customers that cater to a diverse range of health disorders. We are deeply committed to offering innovative healthcare solutions that improve patients’ health and enhance their quality of life. In everything we do or engage with, the foundation remains the same; i.e. an unwavering dedication to quality and innovation.
All our products are manufactured in WHO GMP-certified facilities. With the backing of a strong network, our product range reaches the entire nation with a well-structured distribution channel. Thus, we are highly reliable as a brand when it comes to taking care of the ever-evolving needs of the healthcare community. We offer a wide range of pharmaceutical products for improving patient care, ranging from antibiotics and antifungal treatments to advanced vitamin supplements.
We believe in continuous improvement through research and development, enabling us to stay at the forefront of medical advancements. By combining state-of-the-art technology with a patient-centric approach, we ensure that our solutions not only meet but exceed the expectations of the healthcare sector.